| 引用本文: | 何冰,熊慧瑜,朱枫,蔡飞,刘祯,黄彦,刘佐仁.基于NVivo的广东省医疗机构药物警戒体系现状分析及启示[J].中国现代应用药学,2025,42(10):89-95. |
| He Bing,Xiong Hui Yu,Zhu Feng,Cai Fei,Liu Zhen,Huang Yan,Liu Zuo Ren.Analysis and Implications of the Current Situation of the Drug Vigilance System in Medical Institutions of Guangdong Province Based on NVivo[J].Chin J Mod Appl Pharm(中国现代应用药学),2025,42(10):89-95. |
|
| 摘要: |
| 摘要：目的 分析广东省不同类型、不同级别的医疗机构开展药物警戒工作现状与存在问题，为推进医疗机构药物警戒体系建设提供对策建议。方法 采用分层抽样法，选取广东省9家不同类型、级别医疗机构的药物警戒工作人员进行半结构式访谈，并通过NVivo 12 Plus软件，运用三级编码法对访谈资料进行内容分析。结果 共构建发展现状、存在问题和意见建议3个一级节点、10个二级节点和22个三级节点。广东省医疗机构已初步建立起涵盖人员、制度和平台等方面的药物警戒体系，主要在机构人员、工作开展和资源等方面存在问题。三级综合医院在药物警戒体系建设方面较其他医院深入，不同类型、不同级别医疗机构的存在问题和意见建议侧重点不同。结论 建议加大政策支持，强化机构和制度建设，优化人力资源配置，加强沟通与信息共享，加快信息平台建设，形成覆盖不同等级、兼顾专科医院的药物警戒体系，促进医疗机构药物警戒工作健康可持续发展。 |
| 关键词: 医疗机构 药物警戒体系 质性分析 |
| DOI： |
| 分类号: |
| 基金项目:真实世界数据用于儿童用药上市后安全性评价指标体系以及风险预测模型研究(No.2024SKLDRS0232) |
|
| Analysis and Implications of the Current Situation of the Drug Vigilance System in Medical Institutions of Guangdong Province Based on NVivo |
|
He Bing1, Xiong Hui Yu2, Zhu Feng2, Cai Fei2, Liu Zhen2, Huang Yan2, Liu Zuo Ren1
|
|
1.Guangdong Pharmaceutical University;2.Enter for ADR monitoring of Guangdong
|
| Abstract: |
| ABSTRACT: OBJECTIVE To analyze the current situation and existing problems of pharmacovigilance work in different types and levels of medical institutions in Guangdong Province, and to provide countermeasures and suggestions for promoting the construction of the pharmacovigilance system in medical institutions. METHODS Astratified sampling method was used to select pharmacovigilance staff from 9 medical institutions of different types and levels in Guangdong Province for semi-structured interviews. The interview data were analyzed using the three-level coding method through NVivo 12 Plus software. RESULTS A total of 3 first-level nodes, 10 second-level nodes, and 22 third-level nodes were constructed. Medical institutions in Guangdong Province have initially established a pharmacovigilance system covering personnel, systems, and platforms, but mainly have problems in terms of institutional personnel, work implementation, and resources. Tertiary general hospitals have made more in-depth progress in the construction of the pharmacovigilance system compared to other hospitals. The existing problems and suggestions of different types and levels of medical institutions have different focuses. CONCLUSION It is recommended to increase policy support, strengthen institutional and system construction, optimize human resource allocation, enhance communication and information sharing, accelerate the construction of information platforms, and form a pharmacovigilance system covering different levels and taking into account specialized hospitals to promote the healthy and sustainable development of pharmacovigilance work in medical institutions. |
| Key words: medical institutions pharmacovigilance system qualitative analysis |
